Creative Medical Technology Holdings, Inc.
CELZ
$1.22
-$0.02-1.61%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -34.99% | 75.95% | |||
| Depreciation & Amortization | -6.47% | -0.64% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -25.12% | 53.09% | |||
| Operating Income | 25.01% | -52.85% | |||
| Income Before Tax | 25.64% | -52.74% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 25.64% | -52.74% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 25.57% | -52.74% | |||
| EBIT | 25.01% | -52.85% | |||
| EBITDA | 25.30% | -54.17% | |||
| EPS Basic | 46.02% | -46.84% | |||
| Normalized Basic EPS | 45.98% | -46.84% | |||
| EPS Diluted | 46.02% | -46.84% | |||
| Normalized Diluted EPS | 45.98% | -46.84% | |||
| Average Basic Shares Outstanding | 37.90% | 4.02% | |||
| Average Diluted Shares Outstanding | 37.90% | 4.02% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||